Oramed Pharmaceuticals Inc.
(ORMP) – NasdaqCM

2.98
-0.06 (-1.97%)
Refresh Quote
Exchange :NASDAQ (US Dollar)
Ric Code :ORMP
Volume :22,973
Date :04-03-2020

* Minimum 20 minute delay See terms

Oramed Pharmaceuticals (NASDAQ: ORMP) has developed innovative technology to transform injectable treatments into oral therapies.

Oramed’s flagship product, an oral insulin capsule, can better the lives of millions of diabetics around the world – allowing, amongst other things, type 2 patients to begin insulin therapy earlier without fear of needles… [READ MORE >]

Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19

April 1st, 2020|Comments Off on Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19

- Oral insulin FDA End-of-Phase 2 meeting expected this quarter - Strong balance sheet with roughly $50M in cash - NASH intermediate study data expected this quarter NEW YORK, April 1, 2020 /PRNewswire/ -- Oramed Pharmaceuticals [...]

Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA

March 19th, 2020|Comments Off on Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA

NEW YORK, March 19, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive feedback from its initial [...]

Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million

February 27th, 2020|Comments Off on Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million

NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed" or "Company"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the pricing of an [...]

Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock

February 26th, 2020|Comments Off on Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock

NEW YORK, Feb. 26, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that it intends to offer and [...]